Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc9.1 | Thyroid Disease 2 | ECE2017

Thyroid function and metabolic syndrome: results from the population-based LifeLines Cohort study

Wolffenbuttel Bruce , Wouters Hanneke , Slagter Sandra , van Waateringe Robert , van Vliet-Ostaptchouk Jana , Links Thera , van der Klauw Melanie

Background: The metabolic syndrome (MetS) is a combination of unfavourable health factors including abdominal obesity, dyslipidaemia, hypertension and impaired fasting glucose. Several small-scale studies have reported a relationship between thyroid function and some MetS components or suggested that serum FT3 levels within the normal range were independently associated with insulin resistance. We assessed how thyroid function relates to the prevalence of MetS in a large popul...

ea0037ep927 | Thyroid (non-cancer) | ECE2015

Health-related quality of life is reduced in treated primary hypothyroidism and with lower fT3/fT4-ratio

van Loon Hannah C M , Wouters Hanneke J C M , Kobold Anneke Muller , Slagter Sandra N , Links Thera P , van der Klauw Melanie M , Wolffenbuttel Bruce H R

Introduction: Despite adequate treatment with LT4 monotherapy, many patients with primary hypothyroidism still report complaints, as this treatment can not exactly imitate the endogenous homeostasis. We examined whether the different domains of HR-QOL were affected by the existence of a thyroid disorder and use of LT4 substitution, and whether a lower ratio of free triiodothyronine (fT3)–free thyroxine (fT4)</sup...

ea0056gp247 | Thyroid non cancer | ECE2018

Serum FT4 levels predict incidence of type 2 diabetes and cardiovascular disease in the general population

Wolffenbuttel Bruce HR , van Vliet-Ostaptchouk Jana V , van Waateringe Robert P , Wouters Hanneke JCM. , Slagter Sandra N , Graaff Reindert , van der Klauw Melanie M

Background: Skin autofluorescence (SAF), measured with the AGE-reader, predicts cardiovascular disease (CVD) and type 2 diabetes (T2D). Thyroid hormone levels (TH) may affect this association. In the present study, we examined whether TH predict 4-years risk of T2D, CVD and mortality in the general population independently of SAF.Methods: We included 28245 participants (age 44±12 years, BMI 25.9±4.3 kg/m2) of the Dutch Lifelines Coho...

ea0037gp.26.09 | Thyroid – hypothyroidism | ECE2015

No effect of Thr92Ala DIO2 polymorphisms on thyroid parameters, health-related quality of life, and cognitive functioning

Wolffenbuttel Bruce H R , van Loon Hannah C M , Elderson Martin F , van Vliet-Ostaptchouk Jana V , Wouters Hanneke J C M , Kobold Anneke Muller , Links Thera P , Slagter Sandra N , van der Klauw Melanie M

Introduction: The Thr92Ala polymorphism of deiodinase 2 (DIO2) is associated with increased expression in the brain of genes associated with oxidative stress, and may predict favourable response to combination thyroxine (L-T4) plus triiodothyronine (T3) therapy. We examined whether the Thr92Ala polymorphism (rs225014) was associated with differences in thyroid hormone parameters, health-related quality of life (HR-QOL) and cognitive functio...